The mortality risk of elevated serum transferrin saturation and consumption of dietary iron

Annals of Family Medicine

Volumn 2, Issue 2, 2004, Pages 139-144

  Mainous III, Arch G ^a   Wells, Brian ^a   Carek, Peter J ^a   Gill, James M ^b   Geesey, Mark E ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

Cohort analysis; Mortality; Transferrin

Indexed keywords

TRANSFERRIN;

ADULT; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HEMOCHROMATOSIS; HUMAN; IRON INTAKE; IRON OVERLOAD; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEAT; MORTALITY; SMOKING; STATISTICAL ANALYSIS; TRANSFERRIN BLOOD LEVEL; UNITED STATES; BLOOD; DIET; MIDDLE AGED; RETROSPECTIVE STUDY; SURVIVAL;

ADULT; DIET; FEMALE; HUMANS; IRON OVERLOAD; IRON, DIETARY; MALE; MEAT; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSFERRIN;

EID: 2942633772     PISSN: 15441709     EISSN: None     Source Type: Journal    
DOI: 10.1370/afm.82     Document Type: Article

References (17)

1. McCullen MA, Crawford DHG, Hickman PE. Screening for hemochromatosis. Clinica Qiimica Acta. 2002;315:169-186.
2. Barton JC, Edwards CQ, Bertoli LF, Shroyer TW, Hudson SL. Iron overload in African Americans. Am J Med. 1995;99:616-623.
3. Looker AC, Johnson CL. Prevalence of elevated serum transferrin saturation in adults in the United States. Ann Intern Med. 1998;129: 940-945.
4. Mainous AG III, Gill JM, Pearson WS. Should we screen for hemochromatosis? An examination of evidence of downstream effects on morbidity and mortality. Arch Intern Med. 2002;162:1769-1774.
5. Mainous AG III, Gill JM, Carek, PJ. Elevated serum transferrin saturation and mortality. Ann Fam Med. 2004;2:133-138.
6. Barton JC, McDonnell SM, Adams PC, et al. Management of hemochromatosis. Ann Intern Med. 1998;129:932-939.
7. Witte DL, Crosby WH, Edwards CQ, Fairbanks VF, Mitros FA. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Gin Chim Acta. 1996;245: 139-200.
8. McLaren CE, McLachlan G, Halliday J, et al. Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology. 1998;114:543-549.
9. McCarthy GM, McCarthy CJ, Kenny D, Crowe J, Eustace S. Hereditary hemochromatosis: a common, often unrecognized, genetic disease. Clev Clin J Med. 2002;69:224-237.
10. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenem, Nickel, Silicon, Vanadium, and Zinc: a Report on the Panel of Micronutrients. Washington, DC: National Academy Press; 2001:290-393.
11. Schumann K. Safety aspects of iron in food. Ann Nutrit Metab. 2001;45:91-101.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83.
13. Niederau C, Fischer R, Purshel A, Stremmel W, Haussinger D, Strohmeyer G. Long-term survival in patients with hemochromatosis. Gastroenterology. 1996;110:1107-1109.
14. Jensen OM, Whrendorf J, Rosenquist A, Geser A. The reliability of questionnaire-derived historical dietary information and temporal stability of food habits in individuals. Am J Epidemiol. 1984;120:281-290.
15. James GD, Sealey JE, Alderman MH, Laragh JH. Year to year stability of urine sodium, potassium, aldosterone and PRA in normotensive men and women. Am J Hypertens. 1993;6:86A-90A.
16. Black WC, Haggstrom DA, Welch HG. All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst. 2002;94:167-173.
17. Appleby PN, Throgood M, Mann JI, Key TJ. The Oxford Vegetarian Study: an overview. Am J Clin Nutr. 1999;70:525S-531S.